DN
Therapeutic Areas
Aclaris Therapeutics Pipeline
| Drug | Indication | Phase |
|---|---|---|
| ATI-450 (zunsemetinib) | Rheumatoid Arthritis | Phase 2b |
| ATI-1777 | Atopic Dermatitis | Phase 2b |
| ATI-2138 | Alopecia Areata | Phase 2a |
| Bosakitug (ATI-045) | Atopic Dermatitis | Phase 2 |
| Drug | Indication | Phase |
|---|---|---|
| ATI-450 (zunsemetinib) | Rheumatoid Arthritis | Phase 2b |
| ATI-1777 | Atopic Dermatitis | Phase 2b |
| ATI-2138 | Alopecia Areata | Phase 2a |
| Bosakitug (ATI-045) | Atopic Dermatitis | Phase 2 |